Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2018 Oct 27.
Published in final edited form as: Eat Disord. 2017 Mar 13;25(3):263–272. doi: 10.1080/10640266.2017.1297107

Cost-Effectiveness of Achieving Clinical Improvement with a Dissonance-Based Eating Disorder Prevention Program

Laura Akers 1, Paul Rohde 1, Eric Stice 1, Meghan L Butryn 2, Heather Shaw 1
PMCID: PMC6204073  NIHMSID: NIHMS1501828  PMID: 28287919

Abstract

Using data from an effectiveness trial delivered by college clinicians, we examined the cost-effectiveness of the dissonance-based Body Project program for reducing eating disorder symptoms in women with body dissatisfaction. The outcome of interest was individual-level change; 14.9% of Body Project participants attaining clinically meaningful improvement vs. 6.7% of controls. Delivering the intervention costs approximately $70 (2012 US dollars) per person. Incremental cost-effectiveness was $838 for each additional at-risk person reducing eating disorder symptomology to a clinically meaningful degree. These analyses demonstrate the economic value of the Body Project for college-age women with symptoms below the eating disorder diagnosis threshold.

INTRODUCTION

Approximately 8-15% of young women meet lifetime criteria for DSM-IV anorexia nervosa, bulimia nervosa, or eating disorder not otherwise specified (EDNOS), which includes subthreshold and other eating disorders, such as binge eating disorder (Hudson, Hiripi, Pope, & Kessler, 2007; Wade et al., 2006). These disorders are marked by chronicity, distress, impairment, and risk for obesity, psychopathology, and mortality (Allen, et al., 2013; Arcelus, et al., 2011; Swanson, et al., 2011). Eating pathology has been found to occur along a continuum (Olatunji, et al., 2012; Stice, Killen, et al., 1998, Tylka & Subich, 2003), and individuals with subthreshold bulimia nervosa and binge eating disorders experience functional impairment and emotional distress at rates comparable to those meeting full threshold (Stice, Marti, et al., 2009; Engel, et al., 2009). In addition, subthreshold eating disorders often lead many individuals to seek treatment (Eddy, et al., 2008; Fairburn & Bohn, 2005).

The Body Project is a dissonance-based intervention for women with body dissatisfaction that encourages participants to voluntarily critique the thin beauty ideal in various exercises. Theoretically these activities reduce thin-ideal internalization, which then decreases other eating disorder risk factors, symptoms, and disorder onset. Although intended to prevent eating disorder onset, the intervention also produces improvements in symptom reductions.

Cost-effectiveness analysis helps to allocate finite resources, by determining the ratio of incremental cost to incremental gain for two or more treatments, such as an intervention and a control “treatment.” The result is a ratio between costs (and offsetting savings) in the numerator and a desired non-monetary outcome in the denominator. Decision-makers concerned with achieving this outcome can then compare cost-effectiveness ratios for various treatment programs to decide how best to allocate their financial resources. To date, cost-effectiveness studies have been published for treatment of full-blown eating disorders including in-patient anorexia nervosa treatment (Williamson, et al., 2001; Crow & Nyman, 2004; Byford, et al., 2007; Toulany, et al., 2015) and a self-help program for people meeting DSM-IV criteria for binge eating disorder (Lynch, et al., 2010), and for one program to prevent bulimia nervosa (Wang, et al., 2011), but none has addressed the cost-effectiveness of treating sub-clinical eating disorders.

The present study reports on the cost-effectiveness of the Body Project for clinically meaningful subthreshold symptom reductions, using data from a trial evaluating its effectiveness when delivered by college clinicians (Stice, Butryn, et al., 2013). Given a fixed budget, a university might choose to provide a low-efficacy intervention (i.e., brochures) to a large number of women, or they might prefer to provide a more costly but more effective intervention (i.e., Body Project group) to fewer women, if doing so would produce a greater net gain.

METHODS

Participants were 408 young women (M age = 21.6, SD = 5.6) recruited from eight US universities. Female students and university staff could enroll if they reported body image concerns. Representative of the universities, the sample was 58% European American, 17% Asian, 13% Hispanic, 7% African American, 4% Native American, and 1% Native Pacific Islander. Participants provided informed consent, and the project was approved by institutional review boards at Oregon Research Institute and each campus.

Participants were randomized to the Body Project (n = 203) or an educational brochure condition (which functioned as usual care; n = 205) via a random number table. Participants completed assessments by masked assessors at pretest, posttest, and 1-, 2-, and 3-year follow-ups (see outcome paper for details; Stice, Butryn, et al., 2013). Participants in the two conditions did not differ on demographic variables or pretest outcome values.

Measures

DSM-IV eating disorder symptoms were assessed using the Eating Disorder Diagnostic Interview (EDDI). Past month symptoms were summed to form a composite, which has shown internal consistency (α = .92), inter-rater agreement (ICC = .93), 1-week test-retest reliability (ICC = .95), and sensitivity to interventions (Stice, Butryn, et al., 2013; Burton & Stice, 2006). In this study, the composite showed internal consistency (α = .74), inter-rater agreement (ICC = .84), and 1-week test-retest reliability (ICC = .95).

Analytic Approach

Incremental cost-effectiveness calculation has two components: costs to deliver the intervention and usual care, and program effectiveness, here defined as attaining a clinically meaningful reduction in eating disorder symptoms. Following standard procedures (Farnham, et al., 1996; Gold, et al., 1996), we examine costs associated with replicating the interventions in non-research settings, excluding development/evaluation costs. We use micro-costing (Luce, et al., 1996) rather than gross-costing techniques, identifying costs for each intervention element. Cost data are in 2012 dollars, reflecting the higher end of values for the trial; enrollment was conducted from 2009 to 2011.

Development of the Cost Inventory

Value of clinician time

The primary cost to implementing the Body Project is the time to deliver and receive it. Clinician time is valued according to the U.S. Department of Labor’s (2012) reported median salary for college mental health counselors, with the 25th and 75th percentile salaries used in sensitivity analyses. Fringe benefits were estimated per the 2010/2011 Survey on Employee Benefit Policies and Practices produced by Towers Watson Data Services, which reported median benefits at 18.8% of payroll (25th percentile = 14.4%; 75th percentile = 23.2%). An additional 11% of salary covers statutory employer expenses such as Social Security.

Clinician training

Intervention delivery cost includes cost of training clinicians, averaged over the number of times a typical clinician delivers the intervention. Training has two components: (1) purchase of the 86-page Body Project facilitator guide, which costs $45, and (2) participation in an 8-hour workshop. The workshop typically costs $1250 for up to 16 participants, plus trainer airfare/lodging (http://www.bodyprojectcollaborative.com/training-costs.html). Trainer transportation costs average approximately $500, and because generally 12 people attend each workshop, total costs for arranging the workshop average $150 per clinician-trainee. Clinician’s time is also a cost component and is estimated at 8 hours of workshop attendance.

Trained clinicians typically offer the intervention 2-3 times annually for 2-3 years, a common length of time before staff turnover. Thus, we estimate that the average clinician delivers 6 groups and divide the total per-clinician training cost by 6.

Participant recruitment

Participants are generally recruited by posters advertising a body acceptance group for women, supplemented by local media announcements. The clinician then fields calls from potential participants. Per group, advertising and promotion typically require half an hour of one clinician’s time and minimal materials; fielding calls may take another hour.

Groups

The Body Project intervention entails 4 weekly 1-hour group meetings, ideally led by two clinicians. Each clinician typically spends 5 hours per meeting (4 hours for sessions, plus prep time and other duties). Handout costs are negligible. The intervention is intended to be delivered to groups of 5-9 women; in the effectiveness trial, 203 women participated in 29 groups (7 per group), and this figure is used in the cost estimates. Further, each missed session entails 15 minutes of clinician time for a personalized make-up; in the randomized trial this resulted in 55 make-ups across the 29 groups.

Control condition

Control participants received two mailed brochures: APA Help Center’s three-page guide to “Eating Disorders” and a one-page “Ten Steps to Positive Body Image” brochure from the National Eating Disorders Association. Mailing costs include postage, envelope and cover letter, and labor (approximately one minute of office assistant time).

Assessment of Outcomes of Interest

The outcome of interest was whether the participant attained a clinically meaningful reduction in eating disorder symptoms (EDDI) between baseline and final assessment, a binary outcome that readily permits comparisons between conditions and other interventions. For this outcome, the Reliable Change Index (Jacobson & Truax, 1991) was used. This metric compares the two scores, and “clinically meaningful change” is shown when the difference is least twice the standard error difference (1.96) in the desired direction. The index numerator is the difference in pretest and posttest scores divided by the standard error difference, which is based on the measure’s standard deviation and test-retest reliability.

Cost-Effectiveness Analysis

The incremental cost-effectiveness ratio is calculated as the difference in per-participant costs between conditions (intervention minus control) divided by the difference in condition effectiveness, for each unit of outcome change, assuming that effectiveness for a given outcome is significantly different by condition.

Cost-effectiveness was assessed calculating organizational costs (i.e., costs incurred in replicating the intervention with existing materials), which are the most relevant costs to universities considering whether to adopt the program.

Sensitivity analyses

Incremental cost-effectiveness was also calculated using the higher and lower estimates of clinician’s salary and benefits. The resulting values help set upper and lower cost bounds regionally and over time. Additional analyses show the effects of varying other parameters, e.g., for clinicians to deliver more groups (8 rather than the estimated 6), for one rather than two clinicians to deliver a group, for clinicians to self-train rather than attending a workshop, for clinicians to spend 1-5 hours on recruitment rather than the estimated 1.5 hours, and for groups to have fewer and more participants (4-10, rather than the estimated 7).

RESULTS

Training and Intervention Costs

For this cost analysis, the median clinician wage was $28.91 (75th percentile = $37.03; 25th percentile = $22.42). Training costs under the assumptions above were $71 per clinician per group delivered ($468 per trained clinician divided by 6 groups). Total cost to deliver each intervention group was $488, and per cost per participant was $70. Delivery of the educational brochure intervention costs an organization roughly $1 per person.

Relevant Outcomes

Table 1 presents the rate at which participants attained a clinically meaningful EDDI improvement for intervention (27 of 181 participants, 14.9%) and controls (12 of 179 participants, 6.7%). The difference was significant (χ2 (1, N=360) = 6.285, p < .05). Missing data were not imputed; the 360 participants completing the 3-year follow-up did not differ from the original 408 participants in terms of eating disorder symptoms or risk factors at baseline.

Table 1.

Incremental Cost-Effectiveness of Reducing Eating Disorder Symptoms (EDDI Score) per Individual Attaining a Clinically Meaningful Change (Using Main Analysis Assumptions, Organizational Perspective; Completed Case Analysis)

Condition Cost Per
Participant
Incremental
Cost
Effectiveness:
% Achieving
Change*
Incremental
Effectiveness
Incremental
Cost per
Individual
with CMC*
Brochure Controls 1.01 --- 6.7% --- ---
Body Project 69.75 68.74 14.9% 8.2% $838
*

Clinically Meaningful Change: Control, 12/179; Body Project 27/181; p < .05.

Cost-Effectiveness

Table 1 also presents incremental cost-effectiveness for the individual change measure of eating disordered symptoms. On average, each additional person achieving a clinically meaningful change costs $838 from the organizational perspective.

Sensitivity Analyses

When using the higher clinician cost estimates (75th percentile salary), the incremental cost per participant making a clinically meaningful improvement is $1,045; when using the lower clinician cost estimates (25th percentile salary), the incremental cost is $673.

One of the easiest ways to reduce intervention delivery cost, and thus the cost per person making a clinically meaningful change, is for clinicians to deliver more than 6 groups. If each trained clinician provided 8 groups, the cost per treated person would drop to $65, and the cost per person making the defined improvement would drop to $776. Another way to reduce cost is for only one clinician to deliver the sessions; in the randomized trial, 7 of the 29 groups had only one clinician. This approach reduces the cost per treated person to $39, and the cost per person making the defined improvement to $463. Some motivated clinicians choose to self-train, which involves purchasing the manual and working through it on their own, which takes approximately 6 hours. If two such clinicians worked together to offer 6 groups, the cost per treated person would be $60, and the cost per person making the defined improvement would be $718. Clinicians spending 1 or 5 hours on recruitment would change the cost per person to $813 or $1014. Finally, a group size of 4 would change the cost per person making the defined improvement to $1459, whereas a group size of 10 would change the cost to $590.

The combined least costly scenario - self-trained clinicians offering 8 groups staffed by 1 clinician per group, with 1 hour of recruitment per group yielding 10 participants per group - would cost $433 per person achieving a clinically meaningful reduction in eating disorder symptoms for the median clinician salary. Using the lower and upper salary estimates, the cost per person making the defined improvement would be $356-818.

DISCUSSION

This paper begins to demonstrate the economic value of the Body Project intervention. On average, for every $838 invested in providing groups according to the standard intervention training and protocol instead of brochures, one additional at-risk person (on average) will reduce her eating disorder symptomology by a clinically meaningful degree. Clinicians confident in their ability to maintain intervention fidelity can reduce these costs to as low as $433 under median salary assumptions, but in other circumstances it could cost more than $1,000 to achieve the same outcome. This range of values and factors in the specific delivery setting might influence policy decision makers in their use of this intervention.

It is difficult to say whether this range of cost estimates reflects a good value. To the extent that subthreshold eating disorders interfere with a woman’s education and future earnings, the cost may be quite reasonable. Further, some individuals participating in the Body Project who make a clinically meaningful improvement may otherwise have progressed to a diagnosed eating disorder, and the annual direct costs of an eating disorder have been estimated at $8,042 (Stuhldreher, et al., 2012), which do not take into account additional costs of lost productivity, comorbid depression/anxiety, future obesity, premature morbidity, etc. For such individuals, these costs and the risk of premature death have been averted, and quality of life has been greatly improved. The current study was not designed to include measures of these possible outcomes, and some of them may take many years to manifest; we limited the scope of our analyses to the three-year follow-up period and the available outcomes which we had the statistical power to detect.

Ideally we would like to be able to compare this cost with use of other potential health care resources, which would typically be measured in quality-adjusted life-years saved (QALYs) or disability-adjusted life-years saved (DALYs); a cost per QALY of $50,000 is considered very cost-effective and a threshold of $200,000 per QALY may be reasonable (Ubel, et al., 2003). This calculation would involve assessing health-related quality of life before intervention and at some later point and collecting all costs associated with the symptoms and intervention. One bulimia treatment program estimated a cost per QALY gained of €1,455-€16,481, including only intervention costs and assuming the untreated group would improve linearly to match the treated group within 10 years (Pohjolainen, et al., 2010). However, others caution that QALYs should not be extrapolated beyond a study’s follow-up period when evidence regarding the long-term courses of the different eating disorders is lacking (Stuhldreher, et al., 2012), especially as eating disorder recovery is difficult to definitively ascertain (Aaserudseter, 2007).

Determining the intervention’s cost-effectiveness using societal-level costs, which include the value of participants’ time, averted costs of healthcare received, and associated discontinuities in education and employment, would also be worthwhile. This approach would also permit bootstrapping to estimate uncertainty around the incremental cost-effectiveness ratio, allowing the creation of cost-effectiveness acceptability curves (Fenwick, Claxton, & Sculpher, 2001; Fenwick, O’Brien, & Briggs, 2004) or confidence intervals (O’Brien, et al., 1994). The randomized trial from which the present study drew its data did not have the statistical power to detect differences in healthcare costs, nor did it collect data on lifestyle challenges incurred from subthreshold eating disorder symptoms, so these analyses are beyond the scope of this study.

Future research will explore alternate methods of delivering the Body Project intervention, including group delivery by college peer educators or via a stand-alone web-based program (Stice, Rohde, et al., 2012). Even if these new methods produce smaller effects, their lower cost could result in greater cost-effectiveness.

Supplementary Material

1

ACKNOWLEDGMENTS

We thank Julie Pope, Madeline Kirch, and Colleen Kase for being exemplary project coordinators and thank Jeff Gau for his statistical assistance.

FUNDING

This study was supported by Grant MH086582 from the National Institute of Mental Health.

Footnotes

Supplemental files are available for this article at http://dx.doi.org/10.1080/10640266.2017.1297107.

REFERENCES

  1. Aaserudseter K Defining recovery in Anorexia Nervosa: The importance of concept clarification. Institute of Psychology, University of Oslo; 2007. [Google Scholar]
  2. Allen KL, Byrne SM, Oddy WH, & Crosby RD. DSM-IV-TR and DSM-5 eating disorders in adolescents: prevalence, stability, and psychosocial correlates in a population-based sample of male and female adolescents. J Abnorm Psychol 2013;122:720–32. [DOI] [PubMed] [Google Scholar]
  3. Arcelus J, Mitchell A, Wales J, & Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Arch Gen Psychiatry 2011;68:724–731. [DOI] [PubMed] [Google Scholar]
  4. Burton E, & Stice E. Evaluation of a healthy-weight treatment program for bulimia nervosa: a preliminary randomized trial. Behav Res Ther 2006;44:1727–1738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Byford S, Barrett B, Roberts C, Clark A, Edwards V, Smethurst N, & Gowers SG. Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents. Br J Psychiatry 2007;191:436–440. [DOI] [PubMed] [Google Scholar]
  6. Crow SJ & Nyman JA. The cost-effectiveness of anorexia nervosa treatments. Int J Eat Disord 2004;35:155–160. [DOI] [PubMed] [Google Scholar]
  7. Eddy K, Celio A, Hoste R, Herzog D, & le Grange D Eating disorder not otherwise specified in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2008; 47:156–164. [DOI] [PubMed] [Google Scholar]
  8. Engel SG, Adair CE, Las Hayas C, Abraham S. Health-related quality of life and eating disorders: a review and update. Int J Eat Disord 2009; 42:179–187. [DOI] [PubMed] [Google Scholar]
  9. Fairburn C, & Bohn K (2005). Eating disorder NOS (EDNOS): An example of the trouble-some “not otherwise specified” (NOS) category in DSM-IV. Behaviour Research and Therapy 2005; 43: 691–701. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Farnham PG, Ackerman SP, & Haddix AC. Study design In: Haddix AC, Teutsch SM, Shaffer PA, & Dunet DO (Eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press; 1996 [Google Scholar]
  11. Fenwick E, Claxton K, & Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001;10:779–787. [DOI] [PubMed] [Google Scholar]
  12. Fenwick E, O’Brien BJ, & Briggs A. Cost-effectiveness acceptability curves - facts, fallacies and frequently asked questions. Health Econ 2004;13:405–415. [DOI] [PubMed] [Google Scholar]
  13. Gold MR, Siegel JE, Russell LB, & Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. [Google Scholar]
  14. Hudson J, Hiripi E, Pope H, & Kessler R (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348–358. doi: 10.1016/j.biopsych.2006.03.040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jacobson NS & Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12–19. [DOI] [PubMed] [Google Scholar]
  16. Luce BR, Manning WG, Siegel JE, & Lipscomb J. Estimating costs in cost-effectiveness analysis In: Gold MR, Siegel JE, Russell LB, & Weinstein MC (Eds.), Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996. [Google Scholar]
  17. Lynch FL, Streigel-Moore RH, Dickerson JF, Perrin N, DeBar L, Wilson GT, Kraemer HC. Cost-effectiveness of guided self-help treatment for recurrent binge eating. Journal of consulting and clinical psychology 78.3 (2010): 322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O’Brien BJ, Drummond MF, Labelle RJ, & Willan A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150–163. [DOI] [PubMed] [Google Scholar]
  19. Olatunji B, Broman-Fulks J, Ciesielski B, Zawilinski L, Shewmaker S, & Wall D A taxometric investigation of the latent structure of eating disorders. Psychiatric Research 2012; 197: 97–102. 10.1016/j.psychres.2011.12.016 [DOI] [PubMed] [Google Scholar]
  20. Pohjolainen V, Rasanen P, Roine RP, Sintonen H, Wahlbeck K, & Karlsson H. Cost-utility of treatment of bulimia nervosa. Int J Eat Disord 2010;43:596–602. [DOI] [PubMed] [Google Scholar]
  21. Stice E, Butryn M, Rohde P, Shaw H, & Marti N. An effectiveness trial of a new enhanced dissonance eating disorder prevention program among female college students. Behav Res Ther 2013;51:862–871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Stice E, Killen JD, Hayward C & Taylor CB (1998). Support for the continuity hypothesis of bulimic pathology. Journal of Consulting and Clinical Psychology 1998; 66: 784–790. [PubMed] [Google Scholar]
  23. Stice E, Marti CN, Shaw H, & Jaconis M (2009). An 8-year longitudinal study of the natural history of threshold, subthreshold, and partial eating disorders from a community sample of adolescents. Journal of Abnormal Psychology 2009; 118: 587–597 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stice E, Rohde P, Durant S, & Shaw H. A preliminary trial of a prototype Internet dissonance-based eating disorder prevention program for young women with body image concerns. J Consult Clin Psychol 2012;80:907–916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stuhldreher N, Konnopka A, Wild B, Herzog W, Zipfel S, Löwe B, & König HH. Cost-of-illness studies and cost-effectiveness analyses in eating disorders: A systematic review. Int J Eat Disord 2012;45:476–491. [DOI] [PubMed] [Google Scholar]
  26. Swanson S, Crow S, Le Grange D, Swendsen J, & Merikangas K. Prevalence and correlates of eating disorders in adolescents: Results from the national comorbidity survey replication adolescent supplement. Arch Gen Psychiatry 2011;68:714–723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Toulany A, Wong M, Katzman DK, Akseer N, Steinegger C, Hancock-Howard RL, Coyte PC. Cost analysis of inpatient treatment of anorexia nervosa in adolescents: hospital and caregiver perspectives. CMAJ Open. 2015;3(2):E192–E197. doi: 10.9778/cmajo.20140086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tylka T, & Subich L (2003). Revisiting the latent structure of eating disorders: Taxometric analyses with nonbehavioral indicators. Journal of Consulting and Clinical Psychology 2003; 50: 276–286. 10.1002/eat.22321 [DOI] [Google Scholar]
  29. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn’t it increase at the rate of inflation? Arch Intern Med 2003; 1637–1641. [DOI] [PubMed] [Google Scholar]
  30. Wade T, Bergin J, Tiggemann M, Bulik C, & Fairburn C (2006). Prevalence and long-term course of lifetime eating disorders in an adult Australian twin cohort. Australian and New Zealand Journal of Psychiatry, 40, 121–128. doi: 10.1111/j.1440-1614.2006.01758.x [DOI] [PubMed] [Google Scholar]
  31. Wang LY, Nichols LP, Austin SB. The economic effect of Planet Health on preventing bulimia nervosa. Arch Pediatr Adolesc Med 2011. August;165(8):756–62. [DOI] [PubMed] [Google Scholar]
  32. Williamson DA, Thaw JM, & Varnado-Sullivan PJ. Cost-effectiveness analysis of a hospital-based cognitive-behavioral treatment program for eating disorders. Behav Ther 2001;32:459–477. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

RESOURCES